Morgan Rouprêt mostly deals with Urology, Surgery, Bladder cancer, Cancer and Internal medicine. Morgan Rouprêt has included themes like Carcinoma in situ, Carcinoma, Upper urinary tract and Retrospective cohort study in his Urology study. His studies in Surgery integrate themes in fields like Renal cell carcinoma, Nephrectomy and Kidney disease.
His Bladder cancer study combines topics from a wide range of disciplines, such as Renal pelvis, Urinary system and Cystoscopy. As a member of one scientific family, Morgan Rouprêt mostly works in the field of Cancer, focusing on Pathology and, on occasion, Cancer research and DNA methylation. His Internal medicine study combines topics in areas such as Gynecology and Oncology.
His primary areas of investigation include Internal medicine, Urology, Surgery, Oncology and Bladder cancer. His work in Prostate cancer, Nephrology, Cancer, Carcinoma and Retrospective cohort study is related to Internal medicine. His study in Urology is interdisciplinary in nature, drawing from both Stage, Upper tract, Urothelial carcinoma and Upper urinary tract.
His Surgery research is multidisciplinary, relying on both Urinary system, Renal cell carcinoma and Nephrectomy. His Oncology research is multidisciplinary, relying on both Proportional hazards model and Cohort. His Bladder cancer research includes themes of Carcinoma in situ, Urinary bladder, Disease and Chemotherapy.
Bladder cancer, Internal medicine, Urology, Oncology and Cystectomy are his primary areas of study. His Bladder cancer research is multidisciplinary, incorporating elements of Carcinoma in situ, Clinical endpoint, Disease, Proportional hazards model and Concomitant. His Urology study combines topics in areas such as Cancer, Pathological, Confidence interval, Upper tract and Stage.
His studies examine the connections between Upper tract and genetics, as well as such issues in Logistic regression, with regards to Surgery, Area under the curve and Urothelial carcinoma. Morgan Rouprêt has researched Oncology in several fields, including Systematic review and Immunotherapy. Morgan Rouprêt interconnects Perioperative, Chemotherapy and General surgery in the investigation of issues within Cystectomy.
Morgan Rouprêt mainly investigates Bladder cancer, Urology, Cystectomy, Internal medicine and Surgery. His work carried out in the field of Bladder cancer brings together such families of science as Disease and Intensive care medicine. His Urology research incorporates themes from Carcinoma in situ, Cancer, Pathological, Hazard ratio and Stage.
His biological study spans a wide range of topics, including Perioperative, Radiation therapy, Chemotherapy and Propensity score matching. His study in Internal medicine is interdisciplinary in nature, drawing from both Oncology and 2019-20 coronavirus outbreak. His Surgery research includes elements of Prostatectomy and Urinary diversion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun.
European Urology (2017)
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat.
European Urology (2013)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
M. Babjuk;W. Oosterlinck;R. Sylvester;E. Kaasinen.
European Urology (2011)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2015)
European guidelines on upper tract urothelial carcinomas: 2013 update.
Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2013)
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.
M. Rouprêt;R. Zigeuner;J. Palou;A. Boehle.
European Urology (2011)
Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations
D. Mitropoulos;W. Artibani;M. Graefen;M. Remzi.
European Urology (2012)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero.
European Urology (2019)
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
Giovanni Lughezzani;Maximilian Burger;Vitaly Margulis;Surena F. Matin.
European Urology (2012)
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Karim Bensalah;Allan J. Pantuck;Nathalie Rioux-Leclercq;Rodolphe Thuret.
European Urology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical University of Vienna
Université Paris Cité
Vita-Salute San Raffaele University
University of Montreal
Université Paris Cité
The University of Texas Southwestern Medical Center
Medical University of Graz
Vita-Salute San Raffaele University
Necker-Enfants Malades Hospital
NewYork–Presbyterian Hospital
Jiangnan University
Goethe University Frankfurt
University of Virginia
University of Queensland
Arizona State University
University of Hong Kong
Victoria University of Wellington
University of Sheffield
Shinshu University
Okayama University
Universität Hamburg
Chinese Academy of Sciences
University of Milan
University of Calgary
Institut Gustave Roussy
Harvard University